United States, March 10 -- Sumitomo Corporation, through Sumitomo Corporation of Americas (hereinafter collectively referred to as the "Sumitomo Corporation Group"), has invested (hereinafter, "the Investment") in SHINE Technologies (hereinafter, "SHINE"), a US fusion company that utilizes fusion (nuclear fusion) derived technologies to develop medical isotopes, neutron imaging technology, radioactive waste recycling, and fusion energy.This investment will further strengthen the collaboration based on a memorandum of understanding (MOU) signed in January 2025. To date, the Sumitomo Corporation Group and SHINE have collaborated on expanding medical isotopes, particularly in the Asian market, and on business development in areas where commerc...